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Protein-protein interactionsels are key determinants of cardiac and neuronal excitability. A substantial body
of evidence has accumulated in support of a role for Src family tyrosine kinases in the regulation of Kv
channels. In this study, we examined the possibility that c-Src tyrosine kinase participates in the modulation
of the transient voltage-dependent K+ channel Kv4.3. Supporting a mechanistic link between Kv4.3 and c-Src,
confocal microscopy analysis of HEK293 cells stably transfected with Kv4.3 showed high degree of co-
localization of the two proteins at the plasma membrane. Our results further demonstrate an association
between Kv4.3 and c-Src by co-immunoprecipitation and GST pull-down assays, this interaction being
mediated by the SH2 and SH3 domains of c-Src. Furthermore, we show that Kv4.3 is tyrosine phosphorylated
under basal conditions. The functional relevance of the observed interaction between Kv4.3 and c-Src was
established in patch-clamp experiments, where application of the Src inhibitor PP2 caused a decrease in Kv4.3
peak current amplitude, but not the inactive structural analogue PP3. Conversely, intracellular application of
recombinant c-Src kinase or the protein tyrosine phosphatase inhibitor bpV(phen) increased Kv4.3 peak
current amplitude. In conclusion, our ﬁndings provide evidence that c-Src-induced Kv4.3 channel activation
involves their association in a macromolecular complex and suggest a role for c-Src-Kv4.3 pathway in
regulating cardiac and neuronal excitability.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Kv channels are a complex and heterogeneous family of membrane
proteins which are able to sense and respond to changes in membrane
potential by undergoing conformational changes leading to pore
opening or closing thereby regulating K+ ion ﬂow. Kv4.3, a member of
the Shal subfamily of Kv channels with predominant protein
distribution in brain and heart tissues, has emerged as the leading
candidate K+ channel gene encoding the fast transient outward
current referred to as A-type current in the nervous system and
transient outward K+ current (Ito) in the heart [1,2]. Evidence gathered
in the last few years suggests that transient outward K+ currents
encoded by the Kv4.x gene family in both neuronal and cardiac cellsv4.3, human embryonic kidney
Src homology domains 2 and 3;
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l rights reserved.can be modulated by protein kinases [3–8], to ﬁne-tune Kv channel
activity. Tyrosine phosphorylation along with serine/threonine phos-
phorylation has been gradually accepted as an important regulatory
mechanism in the control of membrane excitability and ion channel
function [9–11]. The non-receptor protein tyrosine kinase (PTK) c-Src
is a prototypical member of a family of nine closely related
membrane-bound kinases deﬁned by a common structure that, in
addition to a catalytic kinase domain, includes amino-terminal
regulatory regions termed Src homology 2 (SH2) and 3 (SH3) domains
(for a review see [12]). These modular domains mediate intramole-
cular and intermolecular interactions that are important in signal
transduction. Voltage- and ligand-gated ion channels have been
reported to interact with the SH2 and SH3 domains of Src kinase and
to cause biophysical changes in channel activity due to the interaction
or to tyrosine phosphorylation by Src [13–17]. Kv4.3 sequence
contains putative SH2 and SH3 domain binding motifs, making
Kv4.3 a strong candidate for direct interaction with and/or phosphor-
ylation by c-Src. It should be stressed that both gating properties and
surface expression of several ion channels can be regulated via
protein-protein interactions with a variety of associated partners
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involving an ion channel and a protein kinase will lead to a higher
probability of channel phosphorylation after kinase activation [15,17].
In the present study we investigated whether c-Src tyrosine kinase
might play a role in the signaling mechanism underlying Kv4.3
regulation using a stable expression strategy. We show, through GST
pull-down assays and co-immunoprecipitation, that Kv4.3 protein
associates with c-Src and that the SH2 and SH3 domains of the kinase
mediate this interaction. This association has important functional
implications, as it may result in enhanced efﬁciency of Kv4.3
phosphorylation by c-Src leading to rapid modulation of Kv4.3 channel
activity in response to signaling pathways linked to c-Src activation.
2. Materials and methods
2.1. Reagents
Primary antibodies used in this study included rabbit polyclonal
antibodies against Kv4.3 (Chemicon, Temecula, CA and Alomone Labs,
Jerusalem, Israel), mouse monoclonal anti-Kv4.3 (provided by Dr.
James S. Trimmer), monoclonal anti-c-Src (clone GD11, Upstate
Biotechnology, Lake Placid, NY), polyclonal anti-Src (SC-18, Santa
Cruz Biotechnology, Santa Cruz, CA), monoclonal anti-phosphotyr-
osine (pY) (clone 4G10, Upstate), polyclonal anti-Src-pY416 (Cell
Signaling, Beverly, MA), polyclonal anti-GST (Santa Cruz), and
polyclonal anti-GAPDH (Novus Biologicals, Littleton, CO). Primary
antibodies were tested for speciﬁcity and cross immunoreactivity.
Secondary antibodies for Western blot were Alexa Fluor 680 anti-
rabbit (Invitrogen, Carlsbad, CA) and IRDye 800 anti-mouse (Rockland
Immunochemicals, Gilbertsville, PA) and immunocytochemistry were
rhodamine-conjugated donkey anti-rabbit IgG and FITC-conjugated
donkey anti-mouse IgG (Jackson ImmunoResearch Laboratories, West
Grove, PA). PP2, PP3 and bpV(phen) were obtained from Calbiochem
(San Diego, CA). Puriﬁed recombinant c-Src kinase was from Upstate.
GST, GST-Src-SH2 and GST-Src-SH3 fusion proteins were purchased
from Panomics (Redwood City, CA). All other reagents were purchased
from Sigma (St. Louis, MO) unless otherwise noted.
2.2. HEK293 cells stably expressing Kv4.3 channels
Because HEK293 cells express endogenous c-Src but not Kv4.3
channels, a stable HEK293 cell line with robust expression of Kv4.3
channel long form (HEK293-Kv4.3) was generated as previously
described [20] and used in the present work. HEK293-Kv4.3 cells were
cultured in 100-mm tissue culture dishes in Dulbecco's Modiﬁed
Eagle's Medium with L-Glutamine (supplemented with 10% heat-
inactivated fetal bovine serum, 400 μg/ml G418, 100 units/ml
penicillin, 100 μg/ml streptomycin) and kept in a humidiﬁed 5% CO2
incubator at 37 °C. Cells were passaged every 6–7 days. For patch-
clamp and immunocytochemistry experiments, cells were plated on
glass coverslips precoated with collagen/poly-D-lysine and used 1–
2 days later.
2.3. Western blot analysis
HEK293-Kv4.3 cells were washed twice in ice-cold PBS and then
scraped into 1 ml of cold lysis buffer (1% NP-40, 1% Na-deoxycholate,
10% glycerol, 150 mM NaCl, 50 mM Tris, 5 mM EDTA) supplemented
with 50 mM NaF, 5 mM Na3VO4, 2 mM PMSF, 1 mM iodoacetamide,
0.15 mM aprotinin, 0.15 mM pepstatin and complete protease
inhibitor cocktail (Roche). The homogenate was cleared by centrifuga-
tion at 16,000 g for 20 min. The supernatant represents the whole-cell
lysate. In some experiments, cytosol and crude membrane fractions
were prepared. Brieﬂy, cells were homogenized in M1 solution
(0.25 M sucrose, 20 mM HEPES, 1 mM EDTA). The homogenate was
centrifuged at 1000 g for 10 min and the resulting supernatant at100,000 g for 60 min. The supernatant was collected (cytosolic
fraction). The pellet, representing the crude membrane fraction, was
solubilized in lysis buffer (see composition above). Equal amounts of
total protein were denatured in SDS sample buffer, resolved on 10%
SDS-PAGE gels and transferred to nitrocellulose membranes. Blots
were blocked with Tris-buffered saline (TBS: 50mM Tris–HCl, 150 mM
NaCl, at pH 7.4) containing 5% nonfat dry milk for 1 h at room
temperature. Thereafter, blots were incubated with indicated primary
antibodies in 1% nonfat milk/TBS with 0.5% Triton X-100 and 0.1%
Tween 20 overnight at 4 °C, washed with TBS three times for 10 min
each, and then incubated with ﬂuorescence-conjugated secondary
antibodies for 1 h. After washing, Western blots were imaged with an
Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE).
The speciﬁcity of the antibodies was tested by preadsorbing with the
antigenic peptide. For c-Src, antigenic peptide was unavailable, and
negative controls were obtained by omitting the primary antibody.
Bands corresponding to the immunoreactive proteins were quantiﬁed
using the Odyssey software.
2.4. Immunocytochemistry
HEK293-Kv4.3 cells grown on glass coverslips were washed twice
with PBS, ﬁxed in 4% paraformaldehyde in PBS for 20 min,
permeabilized in 0.2% Triton X-100 in PBS for 30 min, and blocked
in 5% normal donkey serum/0.2% Triton X-100 in PBS for 30 min at
room temperature. The cells were stained with speciﬁc anti-rabbit
polyclonal against Kv4.3 or anti-mousemonoclonal against pYor c-Src
overnight at 4 °C. After washing with 0.2% Triton X-100 in PBS three
times for 5 min each, the coverslips were stained with rhodamine-
conjugated donkey anti-rabbit IgG and FITC-conjugated donkey anti-
mouse IgG (Jackson ImmunoResearch Laboratories) for 1 h at room
temperature. Cells were washed in PBS three times for 5 min each and
mounted using Prolong antifade (Molecular Probes) and observed
with an Olympus IX-70 confocal ﬂuorescence microscope. Confocal
images were acquired every 0.1 μm in the z plane. Images were 3D
blind deconvoluted using Auto Quant software.
2.5. GST pull-down assay
HEK293-Kv4.3 cells were washed twice in ice-cold PBS and cell
lysates were prepared by adding 1 ml of lysis buffer (see composition
above). GST fusion proteins (3 μg) coupled to glutathione sepharose 4B
beads (Amersham Biosciences, Uppsala, Sweden) were incubated with
2 mg of cell lysates overnight at 4 °C with constant shaking. The beads
were washed four times in 1 ml of ice-cold lysis buffer and immune
complexes were released from the beads by boiling in SDS sample
buffer for 5min. Pull-downproducts were separated on 10% SDS-PAGE
gels and then analyzed byWestern blotting using anti-Kv4.3 and anti-
GST speciﬁc antibodies.
2.6. Co-immunoprecipitation
For co-immunoprecipitation experiments, HEK293-Kv4.3 cells or
HEK293-Kv4.3 cells transfected with c-Src were harvested 48 h post-
transfection, washed twice with ice-cold PBS and scraped into lysis
buffer (see composition above) on ice and clariﬁed by centrifugation.
Total lysate (1 mg) was added to 50 μl of protein A agarose (Pierce
Biotechnology, Rockford, IL) and either 5 μg of monoclonal anti-
Kv4.3 or 5 μg of monoclonal anti-c-Src. A control for nonspeciﬁc
immunoprecipitation was carried out in the absence of primary
antibody. After overnight incubation at 4 °C with constant shaking,
immune complexes were washed twice with lysis buffer and twice
with wash buffer (lysis buffer with 0.1% NP-40) and then extracted
with SDS sample buffer or resuspended in kinase assay buffer for in
vitro kinase experiments. Extracts were resolved on 10% SDS-PAGE
gels, transferred to nitrocellulose membranes, and immunoblotted
Fig. 1. Kv4.3 and c-Src share the same subcellular localization in HEK293 cells stably
transfected with Kv4.3 (HEK293-Kv4.3). (A–C) Co-localization of Kv4.3 and c-Src by
confocal microscopy. HEK293 cells transfected with Kv4.3 grown on coverslips were
ﬁxed with 4% paraformaldehyde and then double-stained with anti-Kv4.3 rabbit
polyclonal antibody (A, red) and anti-c-Src mouse monoclonal antibody (B, green). (C)
Overlay of A and B showing co-localization of Kv4.3 and c-Src (yellow). (D) Fluorescence
intensity proﬁles along the white dashed line showing that Kv4.3 and c-Src labeling are
predominantly co-localized at or near the cell membrane. (E, F) Kv4.3 and c-Src are
enriched in the crude membrane (CM) fractionwhen comparedwith the cytosolic (CYT)
fraction. (G, H) Kv4.3 and c-Src signals were absent when the anti-Kv4.3 antibody was
incubated with the antigenic peptide and the anti c-Src antibody was omitted. Equal
amounts of protein (50 μg) from each fraction were loaded in each lane.
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bodies against Kv4.3 or Src.
2.7. Biotinylation
For biotinylation studies, cells were treated with vehicle, PP2, PP3,
bpV(phen) or transfected with c-Src, and washed twice in PBS2+ (PBS
supplemented with 1 mM MgCl2 and 1 mM CaCl2). Live cells were
biotinylated with 1 mg/ml EZ-Link sulfo-NHS-SS-biotin (Pierce
Biotechnology) in PBS2+ for 30 min at 4 °C. Cells were then washed
three times with 100 mM glycine in PBS2+ to quench unreacted biotin
followed by lysis (see composition above). Total biotinylated mem-
brane proteins (1 mg) were isolated by incubating lysates with 50 μl of
NeutrAvidin agarose beads (Pierce) overnight at 4 °C. The beads were
rinsed three times with lysis buffer (see composition above) before
proteins were eluted with SDS sample buffer.
2.8. Electrophysiology
Whole-cell voltage-clamp recordings were obtained using patch-
clamp ampliﬁer (AxoPatch 200A; Axon Instruments, Union City, CA) at
room temperature. Pipettes were made from glass (PG52150–4; WPI,
Sarasota, FL) and had resistance of 2.5–3.5 MΩ. Voltage-clamp bath
solution was (in mM): 140 Na-MES, 2 KCl, 2 CaCl2, 10 glucose and 10
HEPES, pH 7.4. The pipette solution contained (in mM): 134 K-
Methanesulphonate (K-MES), 6 KCl, 10 HEPES and 10 EGTA, pH 7.2.
Analog signals were ﬁltered at one-ﬁfth of the sampling frequency (1
to 10 kHz). Series resistance were electronically compensated (∼85%);
voltage errors resulting from the uncompensated series resistance
were b10 mV. Current-voltage relationship for the Kv4.3 current was
constructed from the current changes produced by a 500 ms voltage-
clamp step applied in 10 mV increment from the holding potential of
−70 mV. Current recordings were all obtained at a frequency rate of
0.1 Hz. Data acquisition and analysis were performed using custom
made software.
2.9. Statistics
Data were expressed as mean±SEM. Comparisons between two
groups were analyzed by Student's t-test. Statistical signiﬁcance was
set at Pb0.05.
3. Results
3.1. Co-localization of Kv4.3 with c-Src at the plasma membrane in
heterologously expressed cells
We propose that the Kv4.3 channel might be a new target for c-Src
modulation. Accumulating evidence suggests that many ion channels
reside within a multiprotein complex that contains kinases and other
signaling molecules [21,22]. To address whether Kv4.3 and c-Src share
a common subcellular distribution, we used an HEK293 cell line stably
expressing the long form of Kv4.3 (HEK293-Kv4.3) [20] and examined
the subcellular localization of Kv4.3 and c-Src proteins by confocal
microscopy. An antibody speciﬁc to Kv4.3 revealed a continuous
pattern of immunoﬂuorescence staining suggesting a predominant
localization of this protein at the plasma membrane (Fig. 1A).
Similarly, anti-c-Src antibody labeling revealed a major pool of c-Src
protein present at the plasma membrane as well as a minor pool
diffused intracellularly (Fig. 1B). Interestingly, overlapping both
images showed that both proteins displayed co-localization (indicated
by the yellow color) at the plasma membrane (Fig. 1C) that is
conﬁrmed by the ﬂuorescence intensity plot (Fig. 1D). In addition, cell
fractionation experiments were carried out to further conﬁrm that
Kv4.3 and c-Src proteins share the same subcellular microenviron-
ment. As expected from the immunocytochemistry data, Kv4.3 proteinis detected exclusively in crude membrane but not in cytosolic
fractions (Fig. 1E). A Kv4.3 channel speciﬁc antibody labeled a band at
∼68 kDa, which was completely blocked when the antibody was
preincubated with its corresponding antigenic peptide (Fig. 1G). On
the other hand, c-Src antibody labeled a ∼60 kDa band in both
membrane and cytosolic fractions being more abundant in membrane
fractions (Fig. 1F). Antigenic peptide for c-Src antibody was not
available; alternatively, we omitted the primary antibody for negative
control. Under these conditions, the ∼60 kDa band was undetectable
(Fig. 1H). These results suggest that Kv4.3 and c-Src reside on the same
cellular compartment at the plasma membrane, raising the possibility
of a functional interaction between the two proteins.
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Having determined that Kv4.3 can be targeted together with c-Src
to the plasma membrane (Fig. 1), we investigated the physical
interaction between these proteins. Kv4.3 sequence has a total of 24
tyrosine residues, three of which lie within consensus motifs for
tyrosine-speciﬁc phosphorylation (YXX ψ, where ψ can be leucine,
isoleucine or valine [13,23] that could serve upon their phosphoryla-
tion as Kv4.3 docking sites for Src kinase SH2 domain (Fig. 2A, top
panel). Furthermore, three proline-rich sequences in Kv4.3 bearing
the PXXP motif, one in the amino-terminal (26–31) and two in the
carboxy-terminal (618–621; 630–636) of the channel protein could
also interact with Src kinase SH3 domain (Fig. 2A, bottom panel)
[13,24]. We ﬁrst examined whether Kv4.3 could interact with c-Src by
performing an in vitro binding assay using GST fusion proteins with
the Src SH2 and SH3 domains (GST-Src-SH2 and GST-Src-SH3). Pull-
down experiments performed on lysates prepared from HEK293-
Kv4.3 cells showed that Kv4.3 is efﬁciently precipitated by both GST-
Src-SH2 and GST-Src-SH3 but not by GST alone (Fig. 2B) strongly
supporting an interaction between Kv4.3 and Src-SH2 and Src-SH3
domains.
To determine whether Kv4.3-c-Src complexes also occur in intact
cells, we performed co-immunoprecipitation studies in lysates from
HEK293-Kv4.3 cells with endogenous or overexpressed c-Src (Fig. 2C,
left panel). As evidenced by theWestern blot analysis, cells transfected
with Kv4.3 alone or Kv4.3 together with c-Src express similar levels of
Kv4.3 protein (Fig. 2C) indicating that overexpression of c-Src does not
alter expression of Kv4.3. Cell lysates from both cell types wereFig. 2. In vitro and in vivo association between Kv4.3 and c-Src. (A) Kv4.3 consensus sequence
SH3 fusion proteins. Lanes are: cell lysate alone (50 μg protein) or cell lysate incubated with e
beads). Bound Kv4.3 to the GST fusion proteins was precipitated and immunodetected with a
as a loading control for GST fusion proteins. (C) Co-immunoprecipitation of Kv4.3 with c-Src. K
native or transfected c-Src. Cell lysates (1 mg protein) were incubated with 5 μg of anti-Kv4.3
agarose beads, separated on 10% SDS-PAGE, and immunoblotted with polyclonal anti-Kv4.3
extracts (input) used for immunoprecipitation. Middle panels are the immunoprecipitated pr
panels show control reactions carried out in the absence of anti-Kv4.3 (No Ab). (D) The
densitometric analysis and the ratios plotted to determine the degree of associated c-Src nosubjected to immunoprecipitation with anti-Kv4.3 antibody (IP:
Kv4.3; middle panel) or without antibody as control (IP: No Ab;
right panel). The cell lysates and immunoprecipitates were subjected
to immunoblot analysis with speciﬁc antibodies to c-Src (Fig. 2C, top
panel) or Kv4.3 (Fig. 2C, bottom panel). As shown in Fig. 2C, anti-Kv4.3
antibody efﬁciently precipitated Kv4.3 from lysates derived from cells
expressing Kv4.3. A small but detectable amount of endogenous c-Src
was also co-immunoprecipitated together with Kv4.3 which became
more evident after co-expressing c-Src (8-fold increase; Fig. 2C and D)
suggesting that c-Src is a molecular partner of Kv4.3. These results
provide strong evidence supporting the close association between
Kv4.3 and native or co-expressed c-Src kinase.
3.3. Kv4.3 is tyrosine phosphorylated
There is growing evidence supporting a role for Src family PTKs in
the regulation of several ion channel activities by direct tyrosine
phosphorylation [25–28]. Having conﬁrmed an interaction between
Kv4.3 and c-Src (Fig. 2), we next sought to determine whether Kv4.3
channels could be tyrosine phosphorylated. As an initial approach to
test this hypothesis, we examined the subcellular localization of Kv4.3
and phosphotyrosine-containing proteins (pY) by immunoﬂuores-
cence confocal microscopy. We found that immunoreactivities of both
Kv4.3 and pY proteins were present mainly at the plasma membrane
displaying a high degree of co-localization (Fig. 3A) raising the
possibility that Kv4.3 may serve as a potential substrate for plasma
membrane resident tyrosine kinases (e.g. c-Src). To further corrobo-
rate the immunocytochemistry data (Fig. 3A), cells lysates weres for interactionwith c-Src SH2 and SH3 domains. (B) Kv4.3 pull-down by GST-Src-SH2/
ither GST as a control or GST-Src-SH2 or SH3 (GST was coupled to glutathione sepharose
nti-Kv4.3 (top panel). The same blot was probed with anti-GST antibody (bottom panel)
v4.3 was immunoprecipitated (IP) from lysates of stable HEK293-Kv4.3 cells expressing
mouse monoclonal antibody. The immunocomplexes were then captured on protein A
and monoclonal anti-c-Src antibodies. Left panels show immunoblots of the same cell
oteins with anti-Kv4.3 antibody probed with anti-c-Src and anti-Kv4.3 antibodies. Right
c-Src and Kv4.3 blotting signals of the immunoprecipitates were quantiﬁed using
rmalized to the amount of immunoprecipitated Kv4.3.
Fig. 3. Kv4.3 is tyrosine phosphorylated. (A) HEK293-Kv4.3 cells grown on coverslips
were ﬁxed and double-stained with anti-Kv4.3 (red) and anti-phosphotyrosine (pY,
green) antibodies. An overlay of the two images is shown. Fluorescence intensity
proﬁles measured along the white dashed line illustrate a positive correlation between
Kv4.3 and pY ﬂuorescent signals. (B) Kv4.3 and (C) c-Src immunoprecipitates (IP) from
stable HEK293-Kv4.3 cells expressing endogenous c-Src. Each cell lysate (1 mg) was
incubatedwith 5 μg of either anti-Kv4.3 or anti-c-Srcmousemonoclonal antibodies. The
immunocomplexes bound to protein A agarose beads were separated on 10% SDS-PAGE,
and immunoblotted with either polyclonal anti-Kv4.3 or polyclonal anti-c-Src and
monoclonal anti-pY antibodies. Right panels show control reactions carried out in the
absence of antibody (No Ab). Asterisks indicate nonspeciﬁc bands containing the heavy
chain of IgG.
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immunoblotted with both anti-Kv4.3 and anti-pY (Fig. 3B). Interest-
ingly, immunoprecipitated Kv4.3 protein is efﬁciently tyrosine
phosphorylated. As a positive control for tyrosine phosphorylation,
immunoprecipitation using anti-c-Src antibody showed that the
kinase is efﬁciently autophosphorylated (Fig. 3C).3.4. Up-regulation of Kv4.3 currents by constitutively active c-Src
tyrosine kinase
To establish a role for tyrosine phosphorylation on Kv4.3
channel activity, we examined the effect of Src inhibition on
Kv4.3 currents using whole-cell patch-clamp recordings from
HEK293-Kv4.3 cells. As reported in our previous work [20], this
cell line expresses robust Kv4.3 currents (Fig. 4A1). Application of
the membrane-permeable, Src tyrosine kinase inhibitor PP2
(10 μM) [29] to HEK293-Kv4.3 cells resulted in a signiﬁcant
reduction of Kv4.3 peak currents (Fig. 4A2). In addition to the
reduction in current amplitude, PP2 also altered the inactivation
properties of the channel as can be seen in the superimposed
traces shown in Fig. 4A3 from control (a) and after PP2 treatment
(b) at +50 mV. The trace after PP2 treatment was scaled up to
match the peak of the current in control to better show the change
in the inactivation kinetics (Fig. 4A4). The amplitude and the decay
of the outward K+ currents recorded at +50 mV were well ﬁtted
with the sum of two exponential functions (fast and slow
components) and a steady state current. Both time constants of
the fast and slow components of inactivation were signiﬁcantly
decreased by approximately 50% after PP2 application (tfast:
control=27±4 ms vs PP2=14±3 ms; tslow: control=139±22 ms vs
PP2=81±8 ms; n=9 cells). The integrated area of the fast
component at +50 mV was also decreased by PP2 (Afast:
control=3.0±0.4 vs PP2=1.7±0.3; n=9 cells), whereas the inte-
grated area of the slow component was not affected by PP2 (Aslow:
control=1.0±0.1 vs PP2=0.9±0.2). The steady state current was also
signiﬁcantly reduced from 0.28±0.04 in control to 0.15±0.02 in
PP2-treated cells. Fig. 4B shows the peak current density as a
function of voltage in control and after application of PP2. The peak
current density in PP2-treated patches reduced by ∼25–30%
suggesting the existence of a PP2-insensitive pool of channels
which may be uncoupled from c-Src. In support of this view,
application of recombinant c-Src to the whole-cell patches further
increased the current density possibly by stimulating the
uncoupled Kv4.3 channels (see Fig. 5C). The peak current density
in both control and after PP2 treatment were normalized to peak
current density in control condition at +50 mV (Imax) to measure
the channel fractional open probability (Po). The plot of I/Imaxcontrol
showed much lower I/Imaxcontrol in the presence of PP2 (Fig. 4C).
Interestingly, when the same peak currents were normalized to
their corresponding Imax, the curves were superimposed indicating
that the voltage dependence of channel opening remained
unchanged (Fig. 4C, inset). These ﬁndings suggest that Kv4.3
channels that are not functionally coupled to c-Src have the same
voltage dependence of activation and the current reduction can be
explained by the opening of fewer channels or by channels with a
smaller limiting Po value having a faster inactivation rate.
To further emphasize that the effects shown in Fig. 4A–C are due to
PP2, we used PP3, an inactive analogue of PP2, as negative control.
Application of 10 μMPP3 did not alter themagnitude or time course of
membrane currents (Fig. 4D and E).We nextmeasured c-Src activity in
the HEK293-Kv4.3 cell line under control (Ct), PP2 or PP3 treatments
by immunoblotting using an antibody against tyrosine phosphory-
lated proteins (pY) or c-Src autophosphorylation at pY-416, a process
indicative of c-Src activation state [30]. The Src inhibitor PP2 (10 μM;
30 min) almost completely abolished tyrosine phosphorylation of
multiple proteins (Fig. 4F) as well as autophosphorylation of c-Src at
Tyr-416 residue (Fig. 4G), whereas the inactive analogue PP3 (10 μM;
30 min) had no effect (Fig. 4F and G). This result is in agreement with
previous reports showing that PP2, but not PP3, inhibits c-Src activity
analyzed by Western blotting with anti-c-Src-pY416 [31]. The
decrease in c-Src autophosphorylation is not due to differential
expression of c-Src because total c-Src protein levels were not affected
by treatment with either PP2 or PP3 (Fig. 4G).
Fig. 4. PP2, a selective inhibitor of Src family tyrosine kinases, reduces Kv4.3 currents. (A) Kv4.3 currents recorded from the same cell before (A1) and after (A2) exposure to 10 μMPP2
in a HEK293 cell expressing Kv4.3. Cells were voltage-clamped in the whole-cell conﬁgurationwith holding potential (Vh) of −70 mV and stepped from −60 mV to +50 mV in 10-mV
increments with a pulse duration of 500 ms. The voltage step protocol is shown above the traces. Note that outward K+ peak currents become smaller after exposure to PP2. (A3) The
current traces at +50 mV were superimposed for illustration purposes to show the change in both current amplitude and inactivation kinetics before (a) and after PP2 (b) treatment.
(A4) The current trace after PP2 treatment (b) was scaled up to control (a) to better illustrate the change in the inactivation kinetics. (B) Current-voltage relationship of Kv4.3 current
density (pA/pF) before (○) and after (●) PP2 application. (C) Peak current was normalized to the maximum peak current recorded in control at +50 mV (I/Imax), before and after PP2.
Peak currents were also normalized to their corresponding maximum peak currents at +50 mV (Inset). (D) PP3, an inactive structural analogue of PP2, does not signiﬁcantly alter the
peak current of Kv4.3. Current traces to +50 mV showing indistinguishable current in the same cell, before (Control) and after PP3 (10 μM) treatment. (E) Time course of PP2-induced
inhibition and lack of effect of PP3 on Kv4.3 currents. Peak current amplitudes were normalized to the current amplitude before drug treatment (time 0) and plotted against time. (F)
Inhibition by PP2 of protein tyrosine phosphorylation in cell lysates incubated for 30 min in the absence (Ct) or the presence of PP2 or PP3 (both at 10 μM). Immunoblot shows the
protein tyrosine phosphorylation status (pY). (G) c-Src activity was assessed with a phospho-speciﬁc antibody raised against the region of c-Src containing tyrosine-416, the
presumed site of autophosphorylation. The bar graph shows the ratio of phosphorylated c-Src (c-Src-pY416, top panel) to the amount of c-Src protein (c-Src, bottom panel) on each
condition, and normalized to control values. ⁎Pb0.05, PP2 vs control and PP3.
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The previous results strongly suggest that the HEK293-Kv4.3 cell
line has a certain level of basal constitutive c-Src activity, which is
sufﬁcient to phosphorylate either directly or indirectly the Kv4.3
channel causing its activation. In support of this view, application of
the tyrosine phosphatase inhibitor bpV(phen) (10 μM) stimulated
Kv4.3 peak currents by 26% in a time-dependent manner (Fig. 5A and
B), suggesting that the channel has tyrosine residues that are readily
available to be phosphorylated by the constitutive Src kinases. Inaddition, to test more directly the involvement of c-Src, we
determined the effect of intracellular application of the active
recombinant c-Src kinase through the patch-clamp recording pipette
into Kv4.3-expressing HEK293 cells. Application of puriﬁed c-Src
(7.5 U/ml) into the patch pipette induced a signiﬁcant increase by 35%
of the Kv4.3 whole-cell current amplitude (Fig. 5C). bpV(phen) is
known to potently inhibit protein tyrosine phosphatases [32] and
thereby allowing tyrosine residues to remain in a phosphorylated
state. Therefore, we hypothesized that if PP2 acts by blocking c-Src-
dependent phosphorylation of a critical tyrosine residue in Kv4.3
Fig. 5. Potentiation of Kv4.3 currents by a tyrosine phosphatase inhibitor and by active recombinant c-Src. (A) The tyrosine phosphatase inhibitor bpV(phen) signiﬁcantly increased
Kv4.3 peak current. Representative traces show currents recorded at +50 mV from the same cell, before (Control) and after bpV(phen) (10 μM) treatment. (B) Time course of Kv4.3
peak current recorded before (○) and after exposure to 10 μM bpV(phen) (●). Peak current amplitudes were normalized to the current amplitude before treatment at time 0 and
plotted against time. (C) Recombinant c-Src tyrosine kinase (7.5 U/ml) introduced into the patch pipette markedly increased Kv4.3 currents. Recordings are from the same cell before
(Control), and 3 min after perfusion with recombinant c-Src. (D) Current traces from the same cell recorded before (Control, time 0), after PP2 treatment (3 min) and the subsequent
application of PP2+bpV(phen) (6 min) at +50 mV. (E, F) Whole-cell lysates prepared from HEK293-Kv4.3 cells incubated for 30 min in the absence (Ct) or presence of 10 μM bpV
(phen) or co-transfected with c-Src with antibodies against (E) pYor (F) c-Src and c-Src-pY416. (E) Immunosignals show the increased number of tyrosine phosphorylated proteins in
cells treated with bpV(phen) or overexpressing c-Src. Likewise, immunosignals detected with anti-pY indicated that the band at ∼60 kDa, presumably c-Src, increased by bpV(phen)
treatment. (F) c-Src activity was assessed by immunoblotting of cell lysates with a phospho-speciﬁc antibody raised against the region of c-Src containing tyrosine-416, the presumed
site of autophosphorylation. The bar graph shows the ratio of phosphorylated c-Src (c-Src-pY416, top panel) to the amount of c-Src protein (c-Src, bottompanel) under each condition
after normalization to control values. ⁎ Pb0.05, control vs bpV(phen) and c-Src.
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patches with PP2 (10 μM) reduced Kv4.3 peak currents and
subsequent application of bpV(phen) (10 μM) failed to induce any
stimulation of Kv4.3 currents (Fig. 5D). These results suggest that the
magnitude of the opposing activities of c-Src and a tyrosine
phosphatase could therefore dictate the degree of tyrosine phosphor-
ylation of Kv4.3 and its activity. The possibility that the inhibitory
effect of PP2 on Kv4.3 currents may be due to a partial inhibition of
other protein tyrosine kinases cannot be ruled out. A positive
correlation between the phosphorylation state of c-Src and Kv4.3
channel activity was conﬁrmed by measuring the level of autopho-
sphorylated c-Src in lysates fromHEK293-Kv4.3 cells treated with bpV
(phen) (10 μM; 30min) or transfected with c-Src (Fig. 5F). Under these
conditions, multiple proteins were phosphorylated on tyrosineresidues (Fig. 5E). The discrepancy between c-Src fold induction
following bpV(phen) treatment or c-Src overexpression (Fig. 5F) and
corresponding effects on Kv4.3 currents might be due to the fact that
only a small fraction of endogenous c-Src associates with the channel
(Fig. 2C, middle panel). Taken together, these data demonstrate that
the transient outward Kv4.3 current can be constitutively upregulated
by c-Src tyrosine kinase activity.
3.6. c-Src activity does not alter the abundance of Kv4.3 at the plasma
membrane
There is evidence suggesting that signaling pathways can mod-
ulate ion channel activity by affecting the intracellular trafﬁcking of
channel proteins [33–35]. To address whether c-Src modulation of
Fig. 6. Lack of involvement of a Src-dependent synthesis/trafﬁckingmechanism in Kv4.3
regulation. Treatment with PP2, PP3, bpV(phen) or overexpression of c-Src does not
affect the number of Kv4.3 channels in either the total or biotinylated (surface)
fractions. (A) After cell treatment, plasma membrane was biotinylated followed by cell
lysis and incubation of lysates with NeutrAvidin agarose beads to recover surface
biotinylated proteins. Western blots were performed on both total (50 μg protein; left)
and surface (recovered from 1 mg protein; right) fractions with anti-Kv4.3 and anti-
GAPDH (used as a marker of cytosolic proteins) antibodies. The absence of detectable
avidin-bound GAPDH (bottom, right) suggests no contamination by biotinylated
cytosolic proteins. (B) Reactive bands quantiﬁed by densitometric analysis are
presented as ratios of surface over total Kv4.3.
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the plasmamembrane, cells were treated with the Src kinase inhibitor
PP2 (10 μM; 30 min), the inactive analogue PP3 (10 μM; 30 min), the
protein tyrosine phosphatase inhibitor bpV(phen) (10 μM; 30 min) or
transfected with c-Src, and followed by cell surface biotinylation
experiments. Surface expressed proteins were biotinylated on ice for
30 min and then biotinylated proteins were separated by NeutrAvidin
beads, and subsequently analyzed by Western blot. All treatments as
well as c-Src transfection produced no signiﬁcant changes in the
protein levels of Kv4.3 in either the total (Fig. 6A, left panel) or
biotinylated (Fig. 6A, right panel) fractions as compared with
untreated controls (Fig. 6B). Our results suggest that c-Src does not
affect cell membrane targeting and surface distribution patterns of
Kv4.3.
4. Discussion
In the present study we used an HEK293 cell line expressing Kv4.3
and provide evidence, for the ﬁrst time, that Kv4.3 physically interacts
with c-Src and that this interaction has the functional consequence of
increasing channel current amplitude. In addition, we also demon-
strate that Kv4.3 undergoes tyrosine phosphorylation.
There is a large body of evidence indicating that Shaker family K+
channels are regulated by tyrosine kinases. When Kv1.3 is co-
expressed with v-Src in HEK293 cells, the channel becomes tyrosine
phosphorylated and current is suppressed [36]. Similar ﬁndings are
observed upon the coexpression of Kv1.5 and Src [15]. In native
mouse Schwann cells, Fyn-mediated tyrosine phosphorylation of
Kv1.5 leads to channel activation [37]. Therefore, protein tyrosine
phosphorylation appears to be a common important regulatory
mechanism for Shaker superfamily channels. In contrast, no
information is available for Shal-type K+ channels (Kv4.x) regarding
modulation by tyrosine kinases. This superfamily of ion channels has
been reported to be a substrate of several protein kinases, namelyPKC [6], PKA [4], calmodulin-dependent protein kinase II [5,7,8] and
mitogen-activated protein kinase ERK [3]. In this study, we
hypothesized that c-Src may modulate the activity of Kv4.3 via two
distinct mechanisms: i) a direct or indirect protein-protein interac-
tion, which is supported by the presence of potential SH3-binding
domains in Kv4.3; ii) direct phosphorylation of the channel protein,
which is consistent with the presence of three tyrosine phosphoryla-
tion consensus sites in Kv4.3 sequence. Our work presents evidence
supporting a direct physical interaction between c-Src and Kv4.3
channels. The following observations support this conclusion. Firstly,
Kv4.3 was found to cluster at the plasma membrane and co-localize
with c-Src. Secondly, endogenous and transfected c-Src co-immuno-
precipitate with Kv4.3. Finally, GST pull-down assays showed that the
SH2 and SH3 domains of c-Src mediate the interaction between Kv4.3
and the kinase. Kv4.3 might also recruit other SH2- and SH3-
containing signaling molecules into the macromolecular signaling
complex to maintain proper Kv4.3 channel regulation. Because
physical interactions between Src kinases and their substrates are
critical for efﬁcient target phosphorylation [38,39], the interaction
between Kv4.3 and c-Src may also contribute to the rapid and
efﬁcient tyrosine phosphorylation of Kv4.3 channel, thereby regulat-
ing the biophysical properties of the channel. In terms of function our
results indicate that tyrosine phosphorylation of Kv4.3 contributes to
an increase in Kv4.3 channel activity. Recombinant active c-Src and
the tyrosine phosphatase inhibitor bpV(phen) caused an upregula-
tion of Kv4.3 current amplitude in transfected HEK293 cells, whereas
the Src kinase inhibitor PP2 decreased the current. In vitro studies
suggest that PP2 is far more potent at blocking Lck and Fyn than c-Src
[29]. The application of 10 nM PP2 did not affect Kv4.3 currents (not
shown). Thus, the lack of effect of nanomolar PP2 on Kv4.3 channel
activity is compatible with an action of the drug on c-Src, but not Lck
or Fyn. Because the Kv4.3-c-Src complex resides in the plasma
membrane it is appropriately positioned to receive, and respond to,
extracellular signals. This feature explains the fast response of Kv4.3
currents to either Src inhibition or stimulation. At present, it is
unclear how c-Src activates Kv4.3. The results presented here suggest
that c-Src interaction and/or phosphorylation of Kv4.3 channels
translates into an effect on current amplitude, and does not seem to
affect voltage dependence and kinetics of activation of Kv4.3. One
possible scenario is that c-Src kinase controls the number of active
channels or, alternatively, that tyrosine phosphorylation increases the
channel open probability (Po). However, biotinylation experiments
suggest that the abundance of Kv4.3 channels on the plasma
membrane is not regulated by a c-Src-dependent mechanism.
Additional studies will be needed to clarify the molecular details
leading from c-Src to Kv4.3 activation.
Kv4.3 channel activity has been shown to be downregulated in
both physiological and pathological cardiac hypertrophy [40,41].
Interestingly, recent work has shown that an increase in Kv4.3 current
density by in vivo overexpression of Kv4.3 gene abrogates cardiac
hypertrophy [42]. In addition, it has also been shown that cardiac c-Src
activity increases in both physiological [40] and pathological heart
hypertrophy [43]. We speculated that the level of cardiac c-Src activity
is a key factor in controlling the transition from reversible to
irreversible heart hypertrophy [44]. Here, we demonstrate that
Kv4.3 channel activity is increased by c-Src. In the context of both
cardiac physiological and pathological hypertrophy, an increase in
excitability due to tyrosine phosphorylation of Kv4.3 may play a
compensatory role in which cardiac excitability has been
compromised.
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